In this episode of the DeviceTalks Weekly podcast, Amaza Reitmeier shares with Host Tom Salemi why she left the company she never thought she’d leave — Medtronic — to lead Pharaoh Neuro, a company developing a novel approach to treating stroke patients by removing harmful blood from cerebrospinal fluid. Reitmeier shares lessons from her own career and her mentors on timing big moves, learning what you don’t know, and why some of MedTech’s biggest opportunities remain hidden in plain sight.

This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off the registration fee.

Salemi and MassDevice Editor Chris Newmarker offer encouragement to exercising listeners while delivering this week’s Newmarker’s Newsmakers — including updates on cardiology companies, HistoSonics, Boston Scientific, Johnson & Johnson MedTech, Abbott, the Mayo Clinic, and WHOOP.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:08:12) - The biggest cardiology tech stories out of ACC 2026
(00:11:45) - HistoSonics kicks off study using Edison histotripsy system in BPH
(00:14:20) - Boston Scientific completes Valencia Technologies acquisition
(00:16:00) - Johnson & Johnson MedTech shares findings for Impella CP in left ventricle support
(00:16:27) - Abbott joins $575M funding round for wearable maker WHOOP
(00:22:20) - Keynote Interview, Amaza Reitmeier, CEO, Pharaoh Neuro

New Pharaoh CEO Amaza Reitmeier explains why now’s the time to take a leap and lead a CSF startup

DeviceTalks Podcast Network

New Pharaoh CEO Amaza Reitmeier explains why now’s the time to take a leap and lead a CSF startup